Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04758728Completed
Randomised, open-label trial of epinephrine nasal spray in Subcutaneous hematoma, sponsored by Junior Doctors Network-Hellas. Primary endpoint: Number of subcutaneous ecchymoses at 14 days. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04758728.